HKG Equity Snapshot

3378 Weekly Equity Report

Hanx Biopharmaceuticals (Wuhan) Co., Ltd.

Interactive chart JSON snapshot
Latest Close 26.86 HKD 12 Jun 2026
1W Return -6.0% latest completed week
4W Return -16.6% short-term follow-through
12W Return 44.7% quarterly tape
Trend Breadth 0.0% 0 of 24 weeks active
Volume Ratio 1.0x vs 13-week average
Company Brief

What the company does

Hanx Biopharmaceuticals (Wuhan) Co., Ltd. engages in the research and development of immune-oncology therapies. The company's product pipeline includes HX009, a bifunctional anti-PD-1/SIRPa fusion protein that is in Phase IIa clinical trials for the treatment of EBV+ non-Hodgkin lymphoma, acral/mucosal subtype melanoma, relapsed/refractory melanoma post-PD-1 therapy, and Biliary tract cancer; HX044, a CTLA-4/SIRPa bifunctional fusion protein which is in Phase Ia for the treatment of solid tumours; HX301, a novel oral multi-kinase inhibitor that is in Phase IIa for the treatment of glioblastoma; and HX111, an ADC drug candidate to treat solid tumours. It is …

Snapshot

What the weekly tape is saying

3378 closed the latest completed week at 26.86 HKD. The 4-week return is -16.6% and the 12-week return is 44.7%. Trend Signal is inactive, Market Dynamics is 0.00. Setup signature: Risk-first tape with a 34/100 composite read.

Trend Signal Inactive
Market Dynamics No fresh buy
Price vs Trend -
Volume 1.0x
Setup Cockpit

A compressed read of the whole setup

The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.

Composite setup radar

Scoreboard

Trend 0 Persistence of active Trend Signal over the last year and current streak.
Momentum 52 Blend of 4-week and 12-week follow-through.
Dynamics 50 Latest Market Dynamics and whether pressure has improved over four weeks.
Relative Strength 50 Relative leadership and short-term RS change.
Volume 40 Participation compared with the 13-week volume baseline.
Risk Control 15 Drawdown and recent weekly volatility pressure.

16-week signal tape

20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 12 Jun
Weekly return bar Trend Signal dot Positive Market Dynamics dot
Price Action

Price, Trend Line, and Fair Value

Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.

52-week price path

Price Trend Line Fair Value

Price map

Trend Line
-
Vs Trend Line
-
Fair Value
23.48 HKD
Vs Fair Value
14.4%
52W High
32.94 HKD
52W Low
13.48 HKD
Drawdown
-18.5%
Range Position
68.8%
Momentum

Returns and trend persistence

Return windows separate the latest week from short-term and medium-term follow-through.

Return windows

1W -6.0%
4W -16.6%
12W 44.7%
26W -
52W -

Trend read

Active Streak
0 weeks
52W Active Weeks
0
52W Active Breadth
0.0%
Sector Scope
HK Healthcare
Sector Rank
205 of 257
Sector Percentile
20.3%
Peer Context

Sector and industry pulse

Peer breadth helps separate a stock-specific move from a broader group rotation.

Market Dynamics

Pressure, Relative Strength, and expectation

Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.

Dynamics path

Market Dynamics Relative Strength

Signal state

Market Dynamics
0.00
4W MD Change
-
Relative Strength
-
4W RS Change
-
Expectation
Undecided
Probability
52.42%
Volume

Participation and confirmation

Volume tells us whether the latest weekly move is being confirmed by unusual participation.

52-week volume profile

Volume map

Latest Volume
560.5K
13W Average
589.8K
52W Average
1.1M
Vs 13W
1.0x
Vs 52W
0.5x
Risk Anatomy

Volatility, downside weeks, and return shape

A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.

26-week return distribution

Risk map

13W Volatility
11.2%
52W Volatility
9.7%
Upside Weeks
11
Downside Weeks
12
Downside Breadth
52.2%
Avg Gain / Loss
9.7% / -4.3%
Context

Classification, opportunities, risks, and watch points

Top-level read across company classification, constructive evidence, caution points, and the next things that matter.

Classification

Exchange
HKG
Country
HK
Sector
Healthcare
Industry
Biotechnology
Currency
HKD
Market Cap
3.6B

Opportunity signals

  • Price is above Fair Value, showing premium demand versus the model.

Risk signals

  • Trend Signal is inactive, so price action has not confirmed a constructive regime.
  • Market Dynamics is negative, which weakens the current setup.
  • The latest week was a sharp negative move.

Watch next

  • Market Dynamics is the pressure gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Weekly Tape

Recent completed weeks

The latest weekly rows behind the report snapshot.

Week Close Return Trend Fair Value MD RS Volume Signal
12 Jun 2026 26.86 HKD -6.0% - 23.48 HKD 0.00 - 560.5K Off
29 May 2026 28.58 HKD 0.2% - 23.33 HKD 0.00 - 354.8K Off
22 May 2026 28.52 HKD -0.8% - 23.10 HKD 0.00 - 256.7K Off
15 May 2026 28.76 HKD -10.7% - 22.84 HKD 0.00 - 393.9K Off
8 May 2026 32.20 HKD 1.6% - 22.54 HKD 0.00 - 304.6K Off
1 May 2026 31.70 HKD 10.0% - 22.03 HKD 0.00 - 664.5K Off
24 Apr 2026 28.82 HKD -9.9% - 21.50 HKD 0.00 - 627.8K Off
17 Apr 2026 31.98 HKD 6.2% - 21.06 HKD 0.00 - 462.0K Off
10 Apr 2026 30.10 HKD -6.3% - 20.38 HKD 0.00 - 380.0K Off
3 Apr 2026 32.12 HKD 11.8% - 19.73 HKD 0.00 - 614.7K Off
27 Mar 2026 28.72 HKD 22.3% - 18.85 HKD 0.00 - 1.1M Off
20 Mar 2026 23.48 HKD 26.5% - 18.09 HKD 0.00 - 1.6M Off
13 Mar 2026 18.56 HKD -2.4% - 17.64 HKD 0.00 - 435.6K Off
6 Mar 2026 19.02 HKD 8.6% - 17.56 HKD 0.00 - 721.3K Off